Filter
418
Filtered Results: 418
Text search:
seroprevalence
survey
Featured
Recommendations
27
New Publications
135
Language
Document type
No document type
256
Guidelines
59
Studies & Reports
54
Strategic & Response Plan
15
Fact sheets
14
Manuals
12
Situation Updates
5
Resource Platforms
2
Training Material
1
Countries / Regions
Nigeria
23
Global
15
Sierra Leone
13
Congo, Democratic Republic of
13
India
11
Benin
9
Senegal
9
Latin America and the Carribbean
9
South Africa
9
Lesotho
7
Cameroon
7
Africa
7
Tanzania
7
Western and Central Europe
7
Brazil
7
Central African Republic
7
Cambodia
6
Asia
6
Middle East and North Africa
6
Nepal
5
Rwanda
5
Burkina Faso
5
Uganda
5
Eastern Europe
5
Liberia
5
Ukraine
4
Syria
4
West and Central Africa
4
Russia
4
Yemen
4
Zambia
4
Myanmar / Burma
4
Pakistan
4
Colombia
3
Zimbabwe
3
Haiti
3
South–East Asia Region
3
East and Southern Africa
3
Namibia
3
Ethiopia
3
Indonesia
3
Madagascar
3
Kenya
2
Turkey
2
Ghana
2
Afghanistan
2
Peru
2
Malawi
2
Philippines
2
Guinea
2
Mozambique
2
Venezuela
2
Germany
2
Bolivia
2
Bangladesh
2
Vietnam
2
Moldova
2
Somalia
2
North Macedonia
1
Chile
1
Iran
1
Albania
1
Niger
1
Qatar
1
Armenia
1
USA
1
Jordan
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
North America
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Southern Africa
1
Argentina
1
Lebanon
1
Djibouti
1
Egypt
1
Sudan
1
Palestine
1
Honduras
1
Libya
1
Botswana
1
South Sudan
1
Iraq
1
Ecuador
1
Eswatini/ Swaziland
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
68
Studies & Reports
56
Policies
35
COVID-19
20
Statistics
16
Guidelines
14
Hepatitis
13
Women & Child Health
10
Demograhic Health Surveys DHS
9
Capacity Building
9
Disease Prevention & Control
5
Virology
4
Community Health
4
Paediatrics
3
Vector Control
3
Pediatrics
3
Vaccine-preventable Diseases
3
Humanitarian Crisis
3
Gynaecology & Obstetrics
3
Health Systems
3
Communicable Diseases
2
Infection Control & Prevention (IPC)
2
Countries
2
Chagas
2
Clinical Guidelines
2
Disabilities
2
General Guidelines
2
Dengue
2
HIV & STI
2
Humanitarian Aid
1
Monitoring & Evaluation
1
COVID-19
1
Yellow Fever
1
Immunization
1
Quality Control & Assurance
1
Communicable Diseases
1
Needs Assessment
1
NTDs & Others
1
Maternal Health
1
Leishmaniasis
1
Water
1
Pharmacy & Technologies
1
TB
1
Toolboxes
Reports & Studies
19
Infection Control General
13
Prevention & Preparedness
11
TB & Prisoners
10
Educational Settings
9
TB/HIV Coinfection
9
Surveillance
8
For Parents & Children
8
Medical & Community Masks
8
Eastern Europe and central Asia
8
General
7
Surveillance & Contact tracing
7
Children & Adolescents
6
Country specific documents
6
Immunization Guidelines
6
HIV in Key Populations
6
HIV testing & services
5
Context & Facts
5
Global Impact: Socio-economic, health services, TB & HIV
5
Hospital Readiness/Essential Health Services
5
Asia and Pacific
5
Action Plans, Policies & Response
5
TB & Drug Abuse
4
Influenza Prevention & Control
4
Clinical Guidelines
4
Paediatrics
4
TB/HIV
4
Policies and guidelines
4
Substance Use Disorders & Addiction
4
Latin America & the Carribean
4
Clinical Aspects
3
Yellow Fever Prevention & Control
3
Substance Use Disorders, Others
3
Public Health
3
People who injecting Drugs
3
Microcephaly
3
Laboratory
3
Situation Reports & Updates
3
Diagnostics & Laboratory Guidance
3
Appeals and Response Plans
3
Non-pharmaceutical interventions (NPIs)
3
Zoonoses
3
Clinical Aspects & Diagnostics
3
Statistics & Facts
3
Studies & Reports
3
Taeniasis/Cysticercosis
3
Prevention of mother-to-child transmission (PMTCT)
3
Dengue Prevention & Control
3
Clinical Guidelines
3
Preparedness & Prevention
3
Prisoners
3
Eastern and Southern Africa
3
Preparedness & Prevention
3
Policies & Strategies
2
Assessment & Studies
2
HIV in Children and mental health
2
Ebola Prevention & Control
2
Prevention & Control
2
HIV surveillance
2
Hepatitis
2
Eastern Europe
2
Others
2
Vaccination
2
Reports
2
Training, others
2
Simulations
2
Physical Distancing
2
Vaccine Candidates & Research
2
Research & Pipeline
2
General documents One Health
2
Strategies & Roadmaps
2
Studies & Reports
2
Vector control
2
Leptospirosis
2
Health Worker
2
General
2
Disease Prevention & Control
2
TB/HIV Global
2
Roadmaps, Action Plans & Policies
2
HIV service delivery
2
Antiretroviral Treatment ART
2
Reports & Studies Children HIV
2
Epidemiology
2
Africa
1
Drugs
1
Rapid Response
1
Outbreak Prevention & Control
1
Childhood TB
1
Laboratory Guidance
1
Moldova
1
Clinical Aspects, Treatment & Prevention
1
Europe
1
Treatment & Prevention
1
Vaccines & Immunization
1
Studies & Reports
1
Adults
1
South Africa
1
Opportunistic Infections
1
WASH
1
Prevention Guidelines
1
Influenza
1
Context, Facts & Travel Advice
1
National Policies
1
Public Health
1
Treatment Guidelines HIV
1
Namibia
1
Orphans & vulnerable children
1
Laboratory
1
Surveillance
1
HIV
1
Prevention & Control
1
Studies & Reports
1
Cholera Prevention & Control
1
Rwanda
1
Prophylaxis
1
Research
1
Clinical aspects
1
Public Health
1
Workplace
1
Russia
1
Climate & Health
1
Treatment Guidelines
1
Context & Facts, Travel Advice
1
COVID-19
1
Clinical Aspects
1
Public Health
1
PPE Personel Protective Equipment
1
For Health Worker
1
Scientific & Research Studies
1
Workplace
1
Infection Control & Prevention (IPC)
1
Access & Strategy
1
Presentation
1
TB/COVID-19
1
SARS-CoV-2 Variants
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Inactivated COVID-19 Vaccines
1
Midwives
1
Women & Maternal Health
1
One Health
1
Guidelines & Manuals
1
Public Health
1
Infectious Diseases
1
Health Impact & Climate Change
1
MPOX - Monkeypox
1
Best Practice Examples
1
MPOX -Monkeybox Prevention & Control
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Yaws & other Endemic Treponematoses
1
Prevention & Control
1
Access to treatment and laboratory
1
Women
1
Detection & Diagnosis
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Botswana
1
Drug resistant TB
1
Co-Morbidities (except TB)
1
Liberia
1
Neurological Disorders
1
Alzheimer's Disease & Dementia
1
Ghana
1
Zika
1
Malawi
1
For Community Health Workers
1
Research & Access
1
Lesotho
1
Vision Loss & Blindness
1
Clinical Guidelines
1
Situation Reports
1
HIV and coinfection
1
Testing Guidelines
1
Nigeria
1
Chikungunya Prevention & Control
1
Zika Prevention & Control
1
Anxiety Disorders
1
Western & Central Europe
1
Overview & Statistics
1
South-east Asia Region
1
Lobby and Advocacy
1
Laboratory & Diagnostics
1
Kenya
1
The purpose of this document is to share good practices and processes concerning the inclusion of disability issues in HIV policy and programming, drawing on specific experiences in Senegal, Ethiopia, Kenya, Rwanda and Cambodia and on lessons learned at international AIDS conferences.
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af...
Leishmaniases are a group of diseases of zoonotic importance caused by over 20 species of protozoa of the genus Leishmania, in which domestic dogs are considered to be the main reservoir for the disease. However, the involvement of other vertebrates as reservoirs for these parasites has also been in...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
Working towards better COVID-19 outcomes in the WHO European Region.From the first COVID-19 cases in Europe reported on
24 January 2020, the pandemic reached 1 million cases
within 3 months, 10 million cases within 8 months, and
100 million cases in Europe alone within 2 years. Over
the course o...
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re...
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de t...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
COVID Reference 2021.6 EN
recommended
6th edition 13 January 2021 CR 2021.6.10, uploaded on 27 May 2021
Find eight editions: Deutsch | English | Español | Français | Italiano | Português | Tiếng Việt | Türkçe
https://covidreference.com/download
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
